Literature DB >> 23101985

Liver cancer and alcohol.

Priya Grewal1, Vijay Anand Viswanathen.   

Abstract

Annually, hepatocellular carcinoma is diagnosed in approximately a half-million people worldwide. Based on the association of alcohol with cancer, a International Agency for Research on Cancer working group recently deemed alcoholic beverages "carcinogenic to humans," causally related to occurrence of malignant tumors of the oral cavity, pharynx, larynx, esophagus, liver, colorectum, and female breast. Alcohol metabolism in the liver leads to reactive oxygen species production, induction of activity of cytochrome P450s, and reduction of antioxidants. This review analyzes the epidemiology and pathogenesis of alcohol in hepatocellular cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23101985     DOI: 10.1016/j.cld.2012.08.011

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  35 in total

1.  Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes.

Authors:  Tasha Barr; Thomas Girke; Suhas Sureshchandra; Christina Nguyen; Kathleen Grant; Ilhem Messaoudi
Journal:  J Immunol       Date:  2015-11-30       Impact factor: 5.422

Review 2.  Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis.

Authors:  Gianni Testino; Paolo Borro
Journal:  World J Hepatol       Date:  2013-10-27

3.  Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.

Authors:  Luca Quagliata; Matthias S Matter; Salvatore Piscuoglio; Leila Arabi; Christian Ruiz; Alfredo Procino; Michal Kovac; Francesca Moretti; Zuzanna Makowska; Tujana Boldanova; Jesper B Andersen; Monika Hämmerle; Luigi Tornillo; Markus H Heim; Sven Diederichs; Clemente Cillo; Luigi M Terracciano
Journal:  Hepatology       Date:  2014-01-28       Impact factor: 17.425

4.  Trends in Mortality Due to Cancer in the United States by Age and County-Level Income, 1999-2015.

Authors:  Diana R Withrow; Amy Berrington de González; Susan Spillane; Neal D Freedman; Ana F Best; Yingxi Chen; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

Review 5.  Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies?

Authors:  Christine Pocha; Chencheng Xie
Journal:  Transl Gastroenterol Hepatol       Date:  2019-10-09

Review 6.  Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement.

Authors:  Gianni Testino; Patrizia Burra; Ferruccio Bonino; Francesco Piani; Alessandro Sumberaz; Roberto Peressutti; Andrea Giannelli Castiglione; Valentino Patussi; Tiziana Fanucchi; Ornella Ancarani; Giovanna De Cerce; Anna Teresa Iannini; Giovanni Greco; Antonio Mosti; Marilena Durante; Paola Babocci; Mariano Quartini; Davide Mioni; Sarino Aricò; Aniello Baselice; Silvia Leone; Fabiola Lozer; Emanuele Scafato; Paolo Borro
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 7.  Alcohol and hepatocellular carcinoma: a review and a point of view.

Authors:  Gianni Testino; Silvia Leone; Paolo Borro
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

8.  Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma.

Authors:  Xiangting Qiu; Xinhua Wang; Yucui Song; Lingling Chen
Journal:  Dig Dis Sci       Date:  2016-10-03       Impact factor: 3.199

Review 9.  Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.

Authors:  Tracey G Simon; Andrew T Chan
Journal:  Clin Liver Dis       Date:  2020-08-25       Impact factor: 6.126

Review 10.  Human alcohol-related neuropathology.

Authors:  Suzanne M de la Monte; Jillian J Kril
Journal:  Acta Neuropathol       Date:  2013-12-27       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.